VIRTUS
LIVE

Serial Number

86587871

Owner

Virtus Pharmaceuticals, LLC

Attorney

Laurence Tauber

First Use Date

Oct 1, 2011

Filing Date

Apr 6, 2015

Add to watchlist:

No watchlists yet
View on USPTO

VIRTUS Trademark

Serial Number: 86587871 • Registration: 5111954

VIRTUS is a trademark filed by Virtus Pharmaceuticals, LLC on April 6, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Virtus Pharmaceuticals, LLC

Newtown, PA 18940

Entity Type: 16

Trademark Details

Filing Date

April 6, 2015

Registration Date

January 3, 2017

First Use Anywhere

October 1, 2011

First Use in Commerce

October 1, 2011

Published for Opposition

October 18, 2016

Goods & Services

Distributorship services in the field of prescription and over-the-counter drugs; marketing of prescription and over-the-counter drugs

Development of pharmaceutical products

Pharmaceuticals, namely, prescription and over-the-counter drugs for the treatment of illness, disease or deficiencies, namely, bacterial infections, treatment symptoms of seasonal, perennial and chronic allergies and the treatment of skin hives and itching associated with skin reactions, Type 2 diabetes mellitus, Treatment and prevention of osteoporosis in postmenopausal women, treatment to increase bone mass in men with osteoporosis, treatment of glucocorticoid induced osteoporosis, Treatment of Paget's Disease of bone, Treatment for the relief of discomfort associated with acute or painful musculoskeletal conditions, Treatment and management of moderate to moderately-severe pain in adults, Treatment of hypertension, Treatment of diabetic nephropathy, Treatment of dermatitis herpetiformis and leprosy, Treatment of chronic inflammatory skin disease marked by blisters, Treatment of acid indigestion, Treatment of upset stomach, Management and support for patients requiring increased folate levels, Supplementation in support of bone health, Supplementation in support of prenatal health, including, without limitation, increased folic acid, Management and support of absorption of calcium and/or functioning of calcium in the body, Treatment of Vitamin D deficiency, Supplementation in support of postnatal health, Treatment and prevention of lack of vitamins, minerals and/or fatty acids during pregnancy, Treatment and temporary relief of cough, nasal congestion, loosening of phlegm and thin bronchial secretions, Treatment and prevention of prenatal and postnatal folate deficiency, Treatment of elevated or high levels of uric acid and prevention and treatment of metabolic problems caused by kidney disease, prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets, hormone replacement therapy, Postnatal supplementation and improvement of nutritional states of women prior to conception, prevention of acidosis, stomach or bowel problems, peptic ulcers and irritable bowel syndrome, Treatment for excessive saliva production, irritable colon and bladder dysfunction, Treatment of symptoms associated with disorders of gastrointestinal tract, bladder spasms, peptic ulcer disease, diverticulitis, irritable bowel syndrome, cystitis and pancreatitis, Prevention and treatment of low blood levels of potassium, Prevention of Fetal Neural Tube Defects when pregnant, Treatment of inadequate folic acid, folate deficiency, and anemia from inadequate folic acid, Treatment of Hyperhomocysteinemia

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Mar 7, 2026 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sep 8, 2023 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 8, 2023 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 8, 2023 APRE
TEAS SECTION 8 & 15 RECEIVED
Mar 10, 2023 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 3, 2022 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 11, 2017 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 11, 2017 COAR
REGISTERED-PRINCIPAL REGISTER
Jan 3, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 18, 2016 NPUB
PUBLISHED FOR OPPOSITION
Oct 18, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 28, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 14, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 1, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 31, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 31, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 31, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 31, 2016 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 15, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 15, 2016 CRFA
ASSIGNED TO LIE
Aug 13, 2016 ALIE
NOTICE OF REVIVAL - E-MAILED
Aug 5, 2016 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 4, 2016 TROA
PETITION TO REVIVE-GRANTED
Aug 4, 2016 PETG
TEAS PETITION TO REVIVE RECEIVED
Aug 4, 2016 PROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 18, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 18, 2016 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 3, 2016 GNRN
NON-FINAL ACTION E-MAILED
Feb 3, 2016 GNRT
NON-FINAL ACTION WRITTEN
Feb 3, 2016 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 20, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 20, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 20, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 21, 2015 GNRN
NON-FINAL ACTION E-MAILED
Jul 21, 2015 GNRT
NON-FINAL ACTION WRITTEN
Jul 21, 2015 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 20, 2015 GNRN
NON-FINAL ACTION E-MAILED
Jul 20, 2015 GNRT
NON-FINAL ACTION WRITTEN
Jul 20, 2015 CNRT
ASSIGNED TO EXAMINER
Jul 14, 2015 DOCK
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Apr 30, 2015 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Apr 30, 2015 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 14, 2015 NWOS
NEW APPLICATION ENTERED
Apr 9, 2015 NWAP